European Study of Cardiovascular Risk

Study Overview
=================
Brief Summary
-----------------
The main objective of this study is to describe the management of patients with cardiovascular risk factors in primary prevention among different European countries. The patient's participation consists of a single study visit during a routine visit of the patient to the clinic/office. Study variables will be measured: By an interview between physician and patient during the visit and/or available medical records' information: social and demographic patient characteristics, relevant family medical history, current medication. By questions asked to the physician: physician perception of patients' CV risk factor, guidelines adherence and cost-containment. By measurement performed to the patient during the visit: weight, height, BMI, waist and hip circumference will be measured. CV risk factors (blood parameters) will be measured by collecting available data documented within the last year in the medical records and by the collection and analyses of a blood sample during the visit.

Official Title
-----------------
Epidemiological Study of European Cardiovascular Risk Patients: Disease Prevention and Management in Usual Daily Practice

Conditions
-----------------
Cardiovascular Risk Factors, Hyperlipidemia, Hypertension, Diabetes, Obesity, Smoking

Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Provision of informed consent. Patients 50+ years old, with at least one additional CV risk factor (with no previous CV event or hospitalisation for a CV event) from Primary Care or hospital outpatient clinic. Exclusion Criteria: Subjects who are unwilling or unable to provide informed consent Previous CV disease event or hospitalisation for a CV event Current participation in a clinical trial

Ages Eligible for Study
-----------------
Minimum Age: 50 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| 1<br>Patients 50+ years old, with at least one additional CV risk factor (with no previous CV event or hospitalization for a CV event) | |

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| LDL-cholesterol, systolic and diastolic blood pressure, Tot. cholesterol, Non-HDL cholesterol, HDL-cholesterol, waist and hip circumference, HbA1c |  | Cross-sectional | 
| Gender, age, patients with diabetes and/or hypertension (%), smoker status, family medical history. |  | Cross-sectional | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| BMI, Score based 10 year CHD mortality > 5%, High Risk patients (no. and %) |  | Cross-sectional | 
| Use of concomitant medication: anticoagulant, anti hypertensive, antidiabetic, lipid-lowering drugs |  | Cross-sectional | 
| Biomarkers: Apo-A1, Apo-B, Hs-CRP, Creatinine, albuminuria, uric acid, glomerular filtration rate. |  | Cross-sectional | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Cardiovascular risk management, Hyperlipidemia, Hypertension, Diabetes, Obesity